John Vissing

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

Paternal Inheritance of Mitochondrial DNA

Marianne Schwartz, John Vissing · New England Journal of Medicine · 2002 · 692 citations

Life Sciences, Genetics, Molecular Genetics +15

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Howard, Vera Bril, Tuan Vu et al. · The Lancet Neurology · 2021 · 668 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +4

229th ENMC international workshop: Limb girdle muscular dystrophies – Nomenclature and reformed classification Naarden, the Netherlands, 17–19 March 2017

Volker Straub, Alexander P. Murphy, Bjarne Udd et al. · Neuromuscular Disorders · 2018 · 384 citations · Full text

Medicine, Neurology, Neuroscience +15

Recombination of Human Mitochondrial DNA

Yevgenya Kraytsberg, Marianne Schwartz, Timothy A. Brown et al. · Science · 2004 · 305 citations

Medicine, Genetics, Molecular Biology +14